Human Cytomegalovirus Envelope Glycoprotein B Market Trends 2022 | Segmentation, Outlook, Industry Report to 2028

The Human Cytomegalovirus Envelope Glycoprotein B Market size is expected to grow at an annual average of 4% during 2022-2028. Human cytomegalovirus envelope glycoprotein B (gB) Human cytomegalovirus envelope glycoprotein B plays an important role in host cell entry and intercellular virus transmission. It is involved in initial adhesion by binding to heparan sulfate with a gM/gN complex that binds heparin with higher affinity. It interacts with the host integrins ITGB1, PDGFRA and EGFR, which are likely to act as entry receptors after attachment. Participates in the fusion of the virus with the cell membrane, allowing the virus to enter the host cell.

The following segmentation are covered in this report:

By Application

• Infectious Disease
• Oncology
• Women’s Health
• Others

By Type

• CSJ-148
• CyMVectin
• TRL-345
• PPCM
• Cytomegalovirus Vaccine
• Others

Company Profile

• Astellas Pharma Inc.
• Trellis Bioscience, Inc.
• Vakzine Projekt Management GmbH
• VBI Vaccine Inc
• Vical Incorporated

Scope of the report

The research study analyses the Human Cytomegalovirus Envelope Glycoprotein B Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Human Cytomegalovirus Envelope Glycoprotein B Market Report

• What was the  Human Cytomegalovirus Envelope Glycoprotein B Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Human Cytomegalovirus Envelope Glycoprotein B Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.